So far, some studies have described an association between genetic and transcriptomic alterations, showing specific gene expression profiles of different FAB and cytogenic groups22,23, differential isoform usage of genes in MDS patients carrying mutations in spliceosome and non-spliceosome factors17, and alteration of particular subsets of genes with specific splicing mutations21. Here, FANCB is linked to myelodysplastic syndrome.